Pixxoscan 604.72 mg (Gadobutrol SOLUTION) 604.72 MG

Pixxoscan 604.72 mg is a gadobutrol solution used for magnetic resonance imaging (MRI) contrast enhancement. This intravenous solution aids in improving the clarity of MRI scans, helping healthcare professionals visualize internal structures more effectively.

Strength

604.72 MG

Manufacturer / TM Owner

GE HEALTHCARE CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pixxoscan 604.72 mg is primarily used as a contrast agent in MRI procedures. It helps to enhance the visibility of blood vessels, organs, and tissues, making it easier to detect abnormalities. This gadobutrol solution is often utilized in diagnostic imaging to provide clearer images for better evaluation.

Side Effects

When administered intravenously, Pixxoscan 604.72 mg works by temporarily altering the magnetic properties of tissues, which can enhance the contrast in MRI images. This can lead to improved visualization of blood flow and tissue characteristics, aiding in the identification of various conditions.

Precautions & Warnings

Pixxoscan 604.72 mg should be used with caution in individuals with known allergies to gadobutrol or other contrast agents. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

Pixxoscan 604.72 mg may interact with certain medications or substances. It is advisable to consult with a healthcare professional regarding potential interactions, especially with other contrast agents or medications that affect kidney function. Always follow the guidance of a healthcare provider for safe and effective use.

References

Frequently Asked Questions

Pixxoscan 604.72 mg is used as a contrast agent in MRI procedures to enhance the visibility of internal structures.

Pixxoscan 604.72 mg is administered intravenously by a healthcare professional during an MRI scan.

Pixxoscan 604.72 mg temporarily alters the magnetic properties of tissues, enhancing the contrast in MRI images.

Pixxoscan 604.72 mg should be used with caution in individuals with allergies to gadobutrol or other contrast agents.

Pixxoscan 604.72 mg may interact with certain medications, so it is important to consult a healthcare professional.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.